FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107419121> ?p ?o ?g. }

• W2107419121 endingPage "192" @default.
• W2107419121 startingPage "187" @default.
• W2107419121 abstract "A multicentric phase 2 study was conducted to determine the efficiency and the tolerance of imatinib mesylate in children with chronic myelogenous leukemia (CML) in advanced phase of the disease, in relapse after stem cell transplantation, or in case of failure to an interferon α-based regimen. In all, 30 children from eight European countries were enrolled. In 18 children assessable for hematologic response, imatinib mesylate induced complete hematologic response in eight (80%) of the 10 patients included in chronic phase and in six (75%) of eight enrolled in advanced phase of the disease with acceptable toxicity. In 27 patients assessable for cytogenetic response, imatinib mesylate induced disappearance of Philadelphia chromosome-positive bone marrow cells in 12 (60%) of 20 children included in chronic phase and in two (29%) of seven included in advanced phase. A reduction of the bcr-abl/abl ratio to less than 10−4 was achieved in 11 (50%) of the children included in chronic phase. Estimated 12-month overall survival rate was 95% (95% CI, 87–100%) for the patients included in chronic phase and 75% (95%CI, 45–100%) for those enrolled in advanced phase. Imatinib mesylate is well tolerated and molecular remission can be achieved in children with CML." @default.
• W2107419121 created "2016-06-24" @default.
• W2107419121 creator A5012680652 @default.
• W2107419121 creator A5022392635 @default.
• W2107419121 creator A5029284152 @default.
• W2107419121 creator A5029315909 @default.
• W2107419121 creator A5037934940 @default.
• W2107419121 creator A5047925131 @default.
• W2107419121 creator A5059295724 @default.
• W2107419121 creator A5067815591 @default.
• W2107419121 creator A5076801164 @default.
• W2107419121 creator A5079181777 @default.
• W2107419121 creator A5085462928 @default.
• W2107419121 creator A5089621837 @default.
• W2107419121 date "2005-12-08" @default.
• W2107419121 modified "2023-10-16" @default.
• W2107419121 title "Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation" @default.
• W2107419121 cites W1604111726 @default.
• W2107419121 cites W2002959626 @default.
• W2107419121 cites W2011474502 @default.
• W2107419121 cites W2028043713 @default.
• W2107419121 cites W2079517811 @default.
• W2107419121 cites W2082176708 @default.
• W2107419121 cites W2084452268 @default.
• W2107419121 cites W2142900411 @default.
• W2107419121 cites W2142969636 @default.
• W2107419121 cites W2146434689 @default.
• W2107419121 cites W2154169171 @default.
• W2107419121 cites W2171722798 @default.
• W2107419121 cites W2172231214 @default.
• W2107419121 cites W2248768682 @default.
• W2107419121 cites W2312828242 @default.
• W2107419121 cites W2326165099 @default.
• W2107419121 doi "https://doi.org/10.1038/sj.leu.2404051" @default.
• W2107419121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16341042" @default.
• W2107419121 hasPublicationYear "2005" @default.
• W2107419121 type Work @default.
• W2107419121 sameAs 2107419121 @default.
• W2107419121 citedByCount "80" @default.
• W2107419121 countsByYear W21074191212012 @default.
• W2107419121 countsByYear W21074191212013 @default.
• W2107419121 countsByYear W21074191212014 @default.
• W2107419121 countsByYear W21074191212015 @default.
• W2107419121 countsByYear W21074191212016 @default.
• W2107419121 countsByYear W21074191212017 @default.
• W2107419121 countsByYear W21074191212018 @default.
• W2107419121 countsByYear W21074191212019 @default.
• W2107419121 countsByYear W21074191212020 @default.
• W2107419121 countsByYear W21074191212021 @default.
• W2107419121 countsByYear W21074191212022 @default.
• W2107419121 crossrefType "journal-article" @default.
• W2107419121 hasAuthorship W2107419121A5012680652 @default.
• W2107419121 hasAuthorship W2107419121A5022392635 @default.
• W2107419121 hasAuthorship W2107419121A5029284152 @default.
• W2107419121 hasAuthorship W2107419121A5029315909 @default.
• W2107419121 hasAuthorship W2107419121A5037934940 @default.
• W2107419121 hasAuthorship W2107419121A5047925131 @default.
• W2107419121 hasAuthorship W2107419121A5059295724 @default.
• W2107419121 hasAuthorship W2107419121A5067815591 @default.
• W2107419121 hasAuthorship W2107419121A5076801164 @default.
• W2107419121 hasAuthorship W2107419121A5079181777 @default.
• W2107419121 hasAuthorship W2107419121A5085462928 @default.
• W2107419121 hasAuthorship W2107419121A5089621837 @default.
• W2107419121 hasBestOaLocation W21074191211 @default.
• W2107419121 hasConcept C104317684 @default.
• W2107419121 hasConcept C126322002 @default.
• W2107419121 hasConcept C138626823 @default.
• W2107419121 hasConcept C143998085 @default.
• W2107419121 hasConcept C2776694085 @default.
• W2107419121 hasConcept C2776960273 @default.
• W2107419121 hasConcept C2777583451 @default.
• W2107419121 hasConcept C2778461978 @default.
• W2107419121 hasConcept C2778729363 @default.
• W2107419121 hasConcept C2778904597 @default.
• W2107419121 hasConcept C2781413609 @default.
• W2107419121 hasConcept C2911091166 @default.
• W2107419121 hasConcept C3019892230 @default.
• W2107419121 hasConcept C31760486 @default.
• W2107419121 hasConcept C55493867 @default.
• W2107419121 hasConcept C71924100 @default.
• W2107419121 hasConcept C86803240 @default.
• W2107419121 hasConcept C90924648 @default.
• W2107419121 hasConceptScore W2107419121C104317684 @default.
• W2107419121 hasConceptScore W2107419121C126322002 @default.
• W2107419121 hasConceptScore W2107419121C138626823 @default.
• W2107419121 hasConceptScore W2107419121C143998085 @default.
• W2107419121 hasConceptScore W2107419121C2776694085 @default.
• W2107419121 hasConceptScore W2107419121C2776960273 @default.
• W2107419121 hasConceptScore W2107419121C2777583451 @default.
• W2107419121 hasConceptScore W2107419121C2778461978 @default.
• W2107419121 hasConceptScore W2107419121C2778729363 @default.
• W2107419121 hasConceptScore W2107419121C2778904597 @default.
• W2107419121 hasConceptScore W2107419121C2781413609 @default.
• W2107419121 hasConceptScore W2107419121C2911091166 @default.
• W2107419121 hasConceptScore W2107419121C3019892230 @default.
• W2107419121 hasConceptScore W2107419121C31760486 @default.
• W2107419121 hasConceptScore W2107419121C55493867 @default.
• W2107419121 hasConceptScore W2107419121C71924100 @default.

• next